Therefore, it can be suggested that epigenetic changes in MLH1 locus may be a predominant pathway of tumorigenesis in our population rather than inherited mutation of MSI positive endometrial cancers, however more large scale studies with genetic testing is required to validate this observation. This evidence concerns the gene MLH1 and endometrial cancer.